Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges

The cytogenetic abnormalities and molecular mutations involved in acute myeloid leukemia (AML) lead to unique treatment challenges. Although adoptive T-cell therapies (ACT) such as chimeric antigen receptor (CAR) T-cell therapy have shown promising results in the treatment of leukemias, especially B...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Synat, Li, Yisheng, Qiao, Jingqiao, Meng, Xiangyu, He, Ziqian, Gao, Xuefeng, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959347/
https://www.ncbi.nlm.nih.gov/pubmed/35356211
http://dx.doi.org/10.3389/fonc.2022.787108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959347/
https://www.ncbi.nlm.nih.gov/pubmed/35356211
http://dx.doi.org/10.3389/fonc.2022.787108

Ejemplares similares